Savant Capital’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$71.6K Sell
15,462
-559
-3% -$2.48K ﹤0.01% 2354
2026
Q2
$66.6K Buy
16,021
+1,315
+9% +$5.53K ﹤0.01% 1819
2026
Q1
$61K Buy
+14,706
New +$59.7K ﹤0.01% 1484

Other funds holding AQST

Savant Capital's AQST Position: Q3 2026 in Review

Savant Capital reduced its Aquestive Therapeutics (AQST) stake by 3.5% in Q3 2026, selling an estimated $2.48K and leaving 15,462 shares worth $71.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2354.

Savant Capital first reported a position in AQST in Q1 2026 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.

  • Savant Capital held 15,462 shares of Aquestive Therapeutics worth $71.6K as of Q3 2026.
  • Savant Capital sold 559 Aquestive Therapeutics shares in Q3 2026, an estimated $2.48K.
  • Aquestive Therapeutics made up ﹤0.01% of Savant Capital's portfolio in Q3 2026, its #2354 holding.
  • Savant Capital first reported a position in Aquestive Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on Savant Capital's 13F filing for Q3 2026, filed 6 Nov 2026.